Ovarian carcinoma expresses the NKG2D ligand Letal and promotes the survival and expansion of CD28^- antitumor T cellsCONEJO-GARCIA, Jose R; BENENCIA, Fabian; LEVINE, Bruce et al.Cancer research (Baltimore). 2004, Vol 64, Num 6, pp 2175-2182, issn 0008-5472, 8 p.Article

Anesthesia in a patient with chromosome 11;22 translocation : a case report and literature reviewDRUM, Elizabeth T; HERLICH, Andrew; LEVINE, Bruce et al.Paediatric anaesthesia (Paris). 2005, Vol 15, Num 11, pp 985-987, issn 1155-5645, 3 p.Article

Clinical-scale selection of anti-CD3/CD28-activated T cells after transduction with a retroviral vector expressing herpes simplex virus thymidine kinase and truncated nerve growth factor receptorORCHARD, Paul J; BLAZAR, Bruce R; BURGER, Scott et al.Human gene therapy. 2002, Vol 13, Num 8, pp 979-988, issn 1043-0342Article

Efficient priming of protein antigen-specific human CD4⁺ T cells by monocyte-derived dendritic cellsSCHLIENGER, Katia; CRAIGHEAD, Nancy; LEE, Kelvin P et al.Blood. 2000, Vol 96, Num 10, pp 3490-3498, issn 0006-4971Article

Gene expression characteristics of CD28^null memory phenotype CD8⁺ T cells and its implication in T-cell agingFANN, Monchou; WAI KAN CHIU; WOOD, William H et al.Immunological reviews. 2005, Vol 205, pp 190-206, issn 0105-2896, 17 p.Article

Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T Cells Induce Antitumor Activity in Solid MalignanciesBEATTY, Gregory L; HAAS, Andrew R; KALOS, Michael et al.Cancer immunology research (Print). 2014, Vol 2, Num 2, pp 112-120, issn 2326-6066, 9 p.Article

A Novel Dendritic Cell-based Immunization Approach for the Induction of Durable Th1-polarized Anti-HER-2/neu Responses in Women With Early Breast CancerKOSKI, Gary K; KOLDOVSKY, Ursula; ZHANG, Paul et al.Journal of immunotherapy (1997). 2012, Vol 35, Num 1, pp 54-65, issn 1524-9557, 12 p.Article

Stable gene transfer and expression in human primary T cells by the Sleeping Beauty transposon system. CommentaryBUNNELL, Bruce A; XIN HUANG; BLAZAR, Bruce R et al.Blood. 2006, Vol 107, Num 2, issn 0006-4971, 11 p., 416-417,483-491 [11 p.]Article

Regulatory considerations for novel gene therapy products : A review of the process leading to the first clinical lentiviral vectorMANILLA, Peter; REBELLO, Tessio; MACGREGOR, Rob-Roy et al.Human gene therapy. 2005, Vol 16, Num 1, pp 17-25, issn 1043-0342, 9 p.Article

In vitro-expanded human CD4⁺CD25⁺ T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR culturesGODFREY, Wayne R; GE, Ying G; SPODEN, Darrin J et al.Blood. 2004, Vol 104, Num 2, pp 453-461, issn 0006-4971, 9 p.Article

L-Selectin^hi but not the L-selectin^lo CD4⁺25⁺ T-regulatory cells are potent inhibitors of GVHD and BM graft rejectionTAYLOR, Patricia A; PANOSKALTSIS-MORTARI, Angela; SWEDIN, Jessica M et al.Blood. 2004, Vol 104, Num 12, pp 3804-3812, issn 0006-4971, 9 p.Article

HER-2 Pulsed Dendritic Cell Vaccine Can Eliminate HER-2 Expression and Impact Ductal Carcinoma In SituSHARMA, Anupama; KOLDOVSKY, Ursula; PAUL ZHANG et al.Cancer. 2012, Vol 118, Num 17, pp 4354-4362, issn 0008-543X, 9 p.Article

Phase I/II randomized trial of dendritic cell vaccination with or without cyclophosphamide for consolidation therapy of advanced ovarian cancer in first or second remissionCHU, Christina S; BOYER, Jean; VONDERHEIDE, Robert H et al.Cancer immunology and immunotherapy. 2012, Vol 61, Num 5, pp 629-641, issn 0340-7004, 13 p.Article

Cd28-mediated regulation of multiple myeloma cell proliferation and survivalBAHLIS, Nizar J; KING, Anne M; LEE, Kelvin P et al.Blood. 2007, Vol 109, Num 11, pp 5002-5010, issn 0006-4971, 9 p.Article

Suppressor function of umbilical cord blood-derived CD4⁺CD25⁺ T-regulatory cells exposed to graft-versus-host disease drugsPORTER, Stephen B; BAOLING LIU; ROGOSHESKE, John et al.Transplantation. 2006, Vol 82, Num 1, pp 23-29, issn 0041-1337, 7 p.Article

Adoptive Transfer of Autologous T Cells Improves T-cell Repertoire Diversity and Long-term B-cell Function in Pediatric Patients with NeuroblastomaGRUPP, Stephan A; LUNING PRAK, Eline; SULLIVAN, Kathleen E et al.Clinical cancer research (Print). 2012, Vol 18, Num 24, pp 6732-6741, issn 1078-0432, 10 p.Article

4-1 BB and CD28 Signaling Plays a Synergistic Role in Redirecting Umbilical Cord Blood T Cells Against B-Cell MalignanciesTAMMANA, Syam; XIN HUANG; WONG, Marianna et al.Human gene therapy. 2010, Vol 21, Num 1, pp 75-86, issn 1043-0342, 12 p.Article

Multiple Injections of Electroporated Autologous T Cells Expressing a Chimeric Antigen Receptor Mediate Regression of Human Disseminated TumorYANGBING ZHAO; MOON, Edmund; ALBELDA, Steven M et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 22, pp 9053-9061, issn 0008-5472, 9 p.Article

Depletion of endogenous tumor-associated regulatory T cells improves the efficacy of adoptive cytotoxic T-cell immunotherapy in murine acute myeloid leukemiaQING ZHOU; BUCHER, Christoph; WEIGEL, Brenda J et al.Blood. 2009, Vol 114, Num 18, pp 3793-3802, issn 0006-4971, 10 p.Article

Cord blood CD4⁺CD25⁺-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor functionGODFREY, Wayne R; SPODEN, Darrin J; GE, Ying G et al.Blood. 2005, Vol 105, Num 2, pp 750-758, issn 0006-4971, 9 p.Article

A novel system for simultaneous in vivo tracking and biological assessment of leukemia cells and ex vivo generated leukemia-reactive cytotoxic T cellsSAUER, Martin G; ERICSON, Marna E; BLAZAR, Bruce R et al.Cancer research (Baltimore). 2004, Vol 64, Num 11, pp 3914-3921, issn 0008-5472, 8 p.Article

Chimeric Antigen Receptor T Cells for Sustained Remissions in LeukemiaMAUDE, Shannon L; FREY, Noelle; MAHNKE, Yolanda D et al.The New England journal of medicine. 2014, Vol 371, Num 16, pp 1507-1517, issn 0028-4793, 11 p.Article

Rapid Immune Recovery and Graft-versus-Host Disease-like Engraftment Syndrome following Adoptive Transfer of Costimulated Autologous T CellsRAPOPORT, Aaron P; STADTMAUER, Edward A; MILLIRON, Todd et al.Clinical cancer research (Print). 2009, Vol 15, Num 13, pp 4499-4507, issn 1078-0432, 9 p.Article

Targeting HER-2/neu in early breast cancer development using dendritic cells with staged lnterleukin-12 burst secretionCZERNIECKI, Brian J; KOSKI, Gary K; WEINSTEIN, Susan et al.Cancer research (Baltimore). 2007, Vol 67, Num 4, pp 1842-1852, issn 0008-5472, 11 p.Article

A Dendritic Cell Vaccine Pulsed with Autologous Hypochlorous Acid-Oxidized Ovarian Cancer Lysate Primes Effective Broad Antitumor Immunity: From Bench to BedsideCHIANG, Cheryl Lai-Lai; KANDALAFT, Lana E; LEVINE, Bruce L et al.Clinical cancer research (Print). 2013, Vol 19, Num 17, pp 4801-4815, issn 1078-0432, 15 p.Article